MGTX
NASDAQ · Biotechnology
Meiragtx Holdings Plc
$7.62
+0.21 (+2.83%)
Open$7.60
Previous Close$7.41
Day High$7.76
Day Low$7.51
52W High$9.73
52W Low$4.55
Volume—
Avg Volume400.6K
Market Cap591.61M
P/E Ratio—
EPS$-2.11
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+726.9% upside
Current
$7.62
$7.62
Target
$63.01
$63.01
$47.40
$63.01 avg
$83.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 39.16M | 40.82M | 298.22M |
| Net Income | -173,924,544 | -163,173,240 | -30,982,952 |
| Profit Margin | -444.1% | -421.9% | -10.4% |
| EBITDA | -159,676,650 | -158,128,653 | -39,492,333 |
| Free Cash Flow | — | — | -35,501,473 |
| Rev Growth | -4.1% | -4.1% | -0.7% |
| Debt/Equity | 1.08 | 1.08 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |